Atlas Trials

Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients

Clinical trial NCT02588937 · UNKNOWN

Trial details

NCT number
NCT02588937
Sponsor
Chong Kun Dang Pharmaceutical
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2015-10-01
Primary completion
2017-02-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.